Tenax Therapeutics Inc
Biotechnology
Healthcare
TENX
39.57 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.49
52 week high
7.52
high
6.60
52 week low
0.00
low
6.39
growth
82.91 %
previous Close
6.43
P/E ratio
market cap
24.68 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-10.85 M
-4.22 %
eps
0.00 %
3.57 %
eps surprise
39.66 %
net profit margin
-1084700000.00 %
0.00 %
operating incoming
-11.79 M
-4.00 %
net change in cash
-5.99 M
-136.06 %
cash on hand
105 M
-5.37 %
cost of revenue
0.00 %
top top